The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
Open accessAbstract
Cancer, a complex yet common disease, is caused by uncontrolled cell division and abnormal cell growth due to a variety of gene mutations. Seeking effective treatments for cancer is a major research focus as the incidence of cancer is on the rise and drug resistance to existing anti-cancer drugs is major concern. Natural products have the potential to yield unique molecules and combinations of substances that may be effective against cancer with relatively low toxicity/better side effect profile compared to standard anticancer therapy. Drug discovery work with natural products has demonstrated that natural compounds display a wide range of biological activities correlating to anticancer effects. In this review, we discuss formononetin (C16H12O4), which originates mainly from red clovers and the Chinese herb Astragalus membranaceus. The compound comes from a class of 7-hydroisoflavones with a substitution of methoxy group at position 4. Formononetin elicits antitumourigenic properties in vitro and in vivo by modulating numerous signaling pathways to induce cell apoptosis (by intrinsic pathway involving Bax, Bcl-2 and caspase-3 proteins), cell cycle arrest (by regulating mediators like cyclin A, cyclin B1 and cyclin D1), and suppress cell proliferation (by STAT activation, PI3K/AKT and MAPK signaling pathway) and inhibit cell invasion (by regulating growth factors VEGF and FGF2, and MMP-2 and MMP-9 proteins). Co-treatment with other chemotherapy drugs such as bortezomib, LY2940002, U0126, sunitinib, epirubicin, doxorubicin, temozolomide and metformin enhance the anticancer potential of both formononetin and the respective drugs through synergistic effect. Compiling the evidence thus far highlights the potential of formononetin to be a promising candidate for chemoprevention and chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, S., Chen, X., Shan, T., Ma, J., Lin, W., Li, W., & Kang, Y. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.22555 · Cited by 62
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Plants as a source of anti-cancer agents
Cragg, G. M., & Newman, D. J. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.05.011 · Cited by 2,034
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
The mitochondrial membrane potential (Δψm) in apoptosis; an update
Ly, J. D., Grubb, D. R., & Lawen, A. (2003) · Apoptosis · doi:10.1023/a:1022945107762 · Cited by 1,591
Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., & Kroemer, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.367 · Cited by 1,567
Targeting PI3K/Akt/mTOR Signaling in Cancer
Porta, C., Paglino, C., & Mosca, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00064 · Cited by 1,485
Oxidative stress and apoptosis
Kannan, K., & Jain, S. K. (2000) · Pathophysiology · doi:10.1016/s0928-4680(00)00053-5 · Cited by 1,284
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
Walczak, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130
Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes
Deponte, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.018 · Cited by 1,105
Combinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Targeting PI3K/mTOR Signaling in Cancer
Arcaro, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00084 · Cited by 1,024
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Toxic proteins released from mitochondria in cell death
Saelens, X., Festjens, N., Walle, L. V., Gurp, M. V., Loo, G. V., & Vandenabeele, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207523 · Cited by 986
Sui, X., Kong, N., Ye, L., Han, W., Zhou, J., Zhang, Q., He, C., & Pan, H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.019 · Cited by 958
Bioavailability of the polyphenols: Status and controversies
D’Archivio, M., Filesi, C., Varì, R., Scazzocchio, B., & Masella, R. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041321 · Cited by 950
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Carnero, A., Blanco-Aparicio, C., Renner, O., Link, W., & Leal, J. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908784293659 · Cited by 887
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3037 · Cited by 794
Bromberg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15617 · Cited by 770
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Polivka, J., & Janku, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.004 · Cited by 765
TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis
Chicheportiche, Y., Bourdon, P. R., Xu, H., Hsu, Y.-M., Scott, H., Hession, C., Garcia, I., & Browning, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32401 · Cited by 694
Interleukin-6 in human multiple myeloma
Klein, B., Zhang, X., Lu, Z., & Bataille, R. (1995) · Blood · doi:10.1182/blood.v85.4.863.bloodjournal854863 · Cited by 520
Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
Peter, M. E., & Krammer, P. H. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80222-7 · Cited by 498
Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities
Chan, W.-K., Tan, L., Chan, K.-G., Lee, L.-H., & Goh, B.-H. (2016) · Molecules · doi:10.3390/molecules21050529 · Cited by 477
Self-citationPTEN: Multiple Functions in Human Malignant Tumors
Milella, M., Falcone, I., Conciatori, F., Cesta Incani, U., Del Curatolo, A., Inzerilli, N., Nuzzo, C. M. A., Vaccaro, V., Vari, S., Cognetti, F., et al. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00024 · Cited by 463
Suliman, A., Lam, A., Datta, R., & Srivastava, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204282 · Cited by 419
Biodiversity: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2005) · Pure and Applied Chemistry · doi:10.1351/pac200577010007 · Cited by 406
Baek, S. J., Kim, K.-S., Nixon, J. B., Wilson, L. C., & Eling, T. E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09260-5 · Cited by 401
Signaling Pathways that Control Cell Proliferation
Duronio, R. J., & Xiong, Y. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008904 · Cited by 372
Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic
Liu, P., Zhao, H., & Luo, Y. (2017) · Aging and disease · doi:10.14336/ad.2017.0816 · Cited by 347
Mitochondrial Depolarization Accompanies Cytochrome cRelease During Apoptosis in PC6 Cells
Heiskanen, K. M., Bhat, M. B., Wang, H.-W., Ma, J., & Nieminen, A.-L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5654 · Cited by 346
Addressing the Soy and Breast Cancer Relationship: Review, Commentary, and Workshop Proceedings
Messina, M., McCaskill-Stevens, W., & Lampe, J. W. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj356 · Cited by 308
The Role of STATs in Apoptosis
Battle, T., & Frank, D. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362456 · Cited by 284
de Souza Rocha Simonini, P., Breiling, A., Gupta, N., Malekpour, M., Youns, M., Omranipour, R., Malekpour, F., Volinia, S., Croce, C. M., Najmabadi, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1318 · Cited by 267
The emerging role of miR‐375 in cancer
Yan, J., Lin, J., & He, X. (2014) · International Journal of Cancer · doi:10.1002/ijc.28563 · Cited by 238
Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway
Jin, S., Zhang, Q. Y., Kang, X. M., Wang, J. X., & Zhao, W. H. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp499 · Cited by 215
Phosphorylation of the retinoblastoma protein by cdk2.
Akiyama, T., Ohuchi, T., Sumida, S., Matsumoto, K., & Toyoshima, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7900 · Cited by 210
Bioactivation of Phytoestrogens: Intestinal Bacteria and Health
Landete, J. M., Arqués, J., Medina, M., Gaya, P., de Las Rivas, B., & Muñoz, R. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.789823 · Cited by 202
Kim, C., Lee, S.-G., Yang, W. M., Arfuso, F., Um, J.-Y., Kumar, A. P., Bian, J., Sethi, G., & Ahn, K. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.038 · Cited by 195
Resveratrol—Potential Antibacterial Agent against Foodborne Pathogens
Ma, D. S. L., Tan, L. T.-H., Chan, K.-G., Yap, W. H., Pusparajah, P., Chuah, L.-H., Ming, L. C., Khan, T. M., Lee, L.-H., & Goh, B.-H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00102 · Cited by 184
Self-citationChildhood soy intake and breast cancer risk in Asian American women
Korde, L. A., Wu, A. H., Fears, T., Nomura, A. M. Y., West, D. W., Kolonel, L. N., Pike, M. C., Hoover, R. N., & Ziegler, R. G. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0405 · Cited by 181
Tang, C., Hoo, P. C.-X., Tan, L. T.-H., Pusparajah, P., Khan, T. M., Lee, L.-H., Goh, B.-H., & Chan, K.-G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00474 · Cited by 180
Self-citationZhou, R., Xu, L., Ye, M., Liao, M., Du, H., & Chen, H. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1376977 · Cited by 179
Traditional Uses, Phytochemistry, and Bioactivities of Cananga odorata(Ylang-Ylang)
Tan, L. T. H., Lee, L. H., Yin, W. F., Chan, C. K., Abdul Kadir, H., Chan, K. G., & Goh, B. H. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/896314 · Cited by 166
Self-citationMetastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 160
Krueger, J. S., Keshamouni, V. G., Atanaskova, N., & Reddy, K. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204541 · Cited by 159
Rubio-Moscardo, F. (2005) · Blood · doi:10.1182/blood-2005-05-2013 · Cited by 157
Goh, J. X. H., Tan, L. T., Goh, J. K., Chan, K., Pusparajah, P., Lee, L., & Goh, B. H. (2019) · Cancers · doi:10.3390/cancers11060867 · Cited by 155
Self-citationBaxevanis, C. N., Perez, S. A., & Papamichail, M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0576-4 · Cited by 141
Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by l-glutamate
Yu, D., Duan, Y.-L., Bao, Y., Wei, C., & An, L. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.12.027 · Cited by 140
Antimicrobial and antioxidant flavonoids from the root wood of Bolusanthus speciosus
Erasto, P., Bojase-Moleta, G., & Majinda, R. R. T. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.02.011 · Cited by 139
NSAID Activated Gene (NAG-1), a Modulator of Tumorigenesis
Eling, T. E., Baek, S. J., Shim, M., & Lee, C. H. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.6.649 · Cited by 123
Dey, P., Jonsson, P., Hartman, J., Williams, C., Ström, A., & Gustafsson, J.-Α. (2012) · Molecular Endocrinology · doi:10.1210/me.2012.1227 · Cited by 118
Zhang, J., Liu, L., Wang, J., Ren, B., Zhang, L., & Li, W. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.04.014 · Cited by 115
Targeting Membrane Lipid a Potential Cancer Cure?
Tan, L. T., Chan, K., Pusparajah, P., Lee, W.-L., Chuah, L., Khan, T. M., Lee, L., & Goh, B. H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00012 · Cited by 114
Self-citationWang, H., Zhao, L., Zhu, L., Wang, Y., Pan, D., Yao, J., You, Q., & Guo, Q. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22052 · Cited by 109
Chen, J., Zeng, J., Xin, M., Huang, W., & CHEN, X.-L. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1286306 · Cited by 105
Milán‐Noris, A. K., Gutierrez-Uribe, J. A., Santacruz, A., Serna-Saldivar, S. O., & Martínez‐Villaluenga, C. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.06.068 · Cited by 102
Watanabe, S., Uesugi, S., & Kikuchi, Y. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00182-8 · Cited by 100
PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
Jankú, F., Wheler, J. J., Naing, A., Stepanek, V. M. T., Falchook, G. S., Fu, S., Garrido‐Laguna, I., Tsimberidou, A. M., Piha-Paul, S. A., Moulder, S., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.716 · Cited by 99
Microwave-Mediated Synthesis of Anticarcinogenic Isoflavones from Soybeans
Chang, Y.-C., Nair, M. G., Santell, R., & Helferich, W. G. (1994) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00045a007 · Cited by 98
Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft
Au-Yeung, K. K. W., Law, P. C., & Ko, J. K.-S. (2012) · Oncology Reports · doi:10.3892/or.2012.2056 · Cited by 90
Heinonen, S., Wähälä, K., & Adlercreutz, H. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0492767 · Cited by 89
XU, J., Zhang, W., Lv, Q., & Zhu, D. (2015) · Oncology Reports · doi:10.3892/or.2015.3931 · Cited by 88
Wu, X. Y., Xu, H., Wu, Z. F., Chen, C., Liu, J. Y., Wu, G. N., Yao, X. Q., Liu, F. K., Li, G., & Shen, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6310 · Cited by 86
Wu, Y., Zhang, X., Li, Z., Yan, H.-B., Qin, J., & Li, T. (2017) · Food & Function · doi:10.1039/c6fo01535b · Cited by 84
A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine
Turanlı, B., Karagoz, K., Gülfidan, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612824666181106095959 · Cited by 83
Li, T., Zhao, X., Mo, Z., Huang, W., Yan, H., Ling, Z., & Ye, Y. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366342 · Cited by 82
El-Bakoush, A., & Olajide, O. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.016 · Cited by 81
Oak, P., Kopp, F. B., Thakur, C., Ellwart, J. W., Rapp, U. R., Ullrich, A., Wagner, E., Knyazev, P. G., & Roidl, A. (2012) · International Journal of Cancer · doi:10.1002/ijc.27595 · Cited by 75
Ardyanto, T. D., Osaki, M., Tokuyasu, N., Nagahama, Y., & Ito, H. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.3.549 · Cited by 71
Park, S., Bazer, F. W., Lim, W., & Song, G. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27041 · Cited by 68
In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa
Jin, Y., Xu, T., Zhao, Y., Wang, Y., & Cui, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-1302-1 · Cited by 62
Zhang, X., Bi, L., Ye, Y., & Chen, J. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.894098 · Cited by 62
Identifying an isoflavone from the root of Pueraria lobata as a potent tyrosinase inhibitor
Wagle, A., Seong, S. H., Jung, H. A., & Choi, J. S. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.10.008 · Cited by 60
Lu, Z., Zhou, R., Kong, Y., Wang, J., Xia, W., Guo, J., Liu, J., Sun, H., Liu, K., Yang, J., et al. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666151207105720 · Cited by 59
Ingham, J. L. (1976) · Journal of Phytopathology · doi:10.1111/j.1439-0434.1976.tb01741.x · Cited by 58
Fu, D., Zhang, L., Song, J., Mao, R.-W., Zhao, R.-H., Liu, Y., Hou, Y.-H., Li, J., Yang, J., Jin, C., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.027 · Cited by 57
Wang, A., Li, Y., Zhao, Q., & Fan, L. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8857 · Cited by 57
Li, Z., Zeng, G., Zheng, X., Wang, W., Ling, Y., Tang, H., & Zhang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.041 · Cited by 57
Min, X., Wang, Y., Ren, Q., & Guo, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.033 · Cited by 57
Flavanones and rotenoids from the roots of Amorpha fruticosa L. that inhibit bacterial neuraminidase
Kim, Y. S., Ryu, Y. B., Long, M. J. C., Yuk, H. J., Cho, J. K., Kim, J. Y., Kim, K. D., Lee, W. S., & Park, K. H. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.038 · Cited by 53
Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells
Zhang, X., Ni, Q., Wang, Y., Fan, H., & Li, Y. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00002 · Cited by 52
Zeng, M., Sun, R., Basu, S., Ma, Y., Ge, S., Yin, T., Gao, S., Zhang, J., & Hu, M. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500692 · Cited by 51
Kushenol A and 8-prenylkaempferol, tyrosinase inhibitors, derived from Sophora flavescens
Kim, J. H., Cho, I. S., So, Y. K., Kim, H.-H., & Kim, Y. H. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1477776 · Cited by 47
Liu, Y., He, J., Chen, X., Li, J., Shen, M., Yu, W.-J., Yang, Y., & Xiao, Z. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363029 · Cited by 42
Huang, W., Bi, L., Li, Z.-Z., Zhang, X., & Ye, Y. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.842600 · Cited by 35
Flavonoids from Dalbergia ecastophyllum
Matos, F. J. A., Gottlieb, O. R., & Andrade, C. H. S. (1975) · Phytochemistry · doi:10.1016/0031-9422(75)83053-6 · Cited by 35
Chen, J., Zhang, X., Wang, Y., Ye, Y., & Huang, Z. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22531 · Cited by 34
Guo, Y. H., Wang, Y., & Min, X. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1129546 · Cited by 30
Li, S., Chen, P., Chen, L., Lo, Y.-F., Tsai, I., & Wang, E. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.02.159 · Cited by 29
Flavonoids of Baptisia australis (Leguminosae)
Lebreton, P., Markham, K. R., Swift, W. T., Oung-Boran, & Mabry, T. J. (1967) · Phytochemistry · doi:10.1016/s0031-9422(00)82901-5 · Cited by 29
He, Y., Jin, J., Wang, L., Hu, Y., Liang, D., Yang, H., Liu, Y., & Shan, B. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9828-4 · Cited by 27
Guo, B., Liao, C., Liu, X., & Yi, J. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s169767 · Cited by 26
Arshad, O. A., & Datta, A. A. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1522-2 · Cited by 25
Lin, H., Sun, W., Zheng, C.-S., Han, H., Wang, X., Zhang, Y., Qiu, H., Tang, C., Qi, J., Lu, G., et al. (2017) · RSC Advances · doi:10.1039/c7ra09825a · Cited by 24
In vitro and in vivo studies of antiosteosarcoma activities of formononetin
Hu, W., Wu, X., Tang, J., Xiao, N., Zhao, G., Zhang, L., & Ou, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28349 · Cited by 23
Huang, J., Xie, M., Gao, P., Ye, Y., Liu, Y., Zhao, Y., Luo, W., Ling, Z., Cao, Y., Zhang, S., et al. (2015) · Process Biochemistry · doi:10.1016/j.procbio.2015.03.001 · Cited by 22
Vishnuvarthan, V. J., Lakshmi, K. S., & Srividya, A. R. (2017) · Journal of Young Pharmacists · doi:10.5530/jyp.2017.9.33 · Cited by 17
Huang, Q., Xu, L., Qu, W.-S., Ye, Z.-H., Huang, W.-Y., Liu, L.-Y., Lin, J.-F., Li, S., & Ma, H. (2016) · European Food Research and Technology · doi:10.1007/s00217-016-2820-z · Cited by 13
Guo, Y., Tang, F.-Y., Wang, Y., Huang, W., Tian, J., Lü, H., Min, X., & Chen, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21923 · Cited by 9
Wagenaar, T. R., Hotz, C., Gieseke, F., Cao, H., Diekmann, J., Diken, M., Grunwitz, C. R., Hebert, A., Hsu, K., Jordan, M., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-lb-130 · Cited by 5
Metadata
- Authors
- Tay, K.-C., Tan, L. T.-H., Chan, C. K., Hong, S. L., Chan, K.-G., Yap, W. H., Pusparajah, P., Lee, L.-H., & Goh, B.-H.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-07-26
- Volume
- 10
- Pages
- 820-820
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2964456700
- Cited by
- 294
- References
- 112
- FWCI
- 16.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.